In a recent note, Kaumil Gajrawala from Jefferies has assigned The Clorox Company (ticker: CLX) a “Hold” rating as of July 28, 2026, reflecting a cautious approach towards the company’s future performance. With the stock currently trading at $97.41, near its target price of $98, this rating signals potential upside while also indicating a hesitation to fully endorse stronger investment action at this juncture. As investors mull this shift in sentiment, understanding its implications for Clorox’s market position and financial health becomes paramount.
Recent Price Action
In the last trading sessions, CLX has shown a modest increase, up $1.95 (approximately 1.99%), indicating a slight positive sentiment among investors. The stock’s current price of $97.41 is situated significantly below its 52-week high of $117.56, reflecting a downward trend in market confidence, particularly over the past year. The nearly 26% decrease from this high, alongside a considerable distance from the 52-week low of $31.27, underscores the volatility that has characterized Clorox’s stock performance. Trading volumes have also been noteworthy; with 1,043,271 shares exchanged recently, the stock has seen lower activity compared to its average volume of 2,915,903, suggesting cautious trading behavior among investors. A beta of 0.531 indicates that the stock is less volatile than the broader market, which may attract conservative investors looking for stability.
Historical Performance
Analyzing Clorox’s performance over different time horizons reveals a mixed picture. The company’s stock has posted an 8.2% increase over the past 30 days, suggesting recent recovery efforts. However, the quarterly performance reflects a decline of 8.25%, highlighting challenges in adapting to market conditions. Over a one-year period, CLX has experienced a more troubling trend, with a significant decrease of 31.55%. The stock’s volatility metrics also reflect this inconsistency, with weekly volatility at 2.26 and monthly volatility at 2.14, pointing to fluctuations that have left many investors wary.
Earnings Analysis
In the latest earnings report, Clorox delivered an earnings per share (EPS) of $1.54, just shy of the $1.55 estimate, resulting in a surprise factor of -0.65%. This marks a continuation of an earnings miss, following a previous quarter where the company reported an EPS of $1.39 against an estimate of $1.43, indicating a surprise of -2.80%. Such performance not only reflects ongoing operational challenges but also suggests a need for the company to enhance its earnings predictability moving forward. As investors look for stability and growth, these missed expectations could weigh heavily on market sentiment.
Analyst / Consensus View
Investor sentiment around Clorox is notably mixed, as reflected in the broader analyst consensus. Out of a total of 13 ratings, the stock received 7 holds and 6 sells, with no buy ratings to stimulate optimism. The average price target stands at approximately $95.92, slightly below its current trading price, suggesting that many analysts see limited upside potential at this time. The range of price targets illustrates further divergence in analyst thinking, with prices ranging from a low $85 to a high of $110, emphasizing the uncertainty surrounding Clorox’s near-term outlook.
Stock Grading or Fundamental View
The Stocks Telegraph Grade (ST Score) for Clorox is currently 51, which indicates that while the company maintains a degree of operational health, it is facing considerable headwinds that could impact its future viability. This score encapsulates various factors, including financial performance, market positioning, and competitiveness in the sector. Investors seeking stocks with strong fundamentals may find Clorox’s score indicative of cautious engagement rather than robust endorsement.
Conclusion
For investors, Clorox represents a complex opportunity. Those looking for defensive plays may find the stock’s lower volatility appealing, but current analysts’ ratings and mixed financial performance suggest it may be more suitable for those with a higher risk tolerance willing to navigate uncertainty. Given the missed earnings expectations, fluctuating stock value, and the lack of buy ratings, prospective investors should approach with caution, prepared for potential volatility and challenges ahead. Keeping an eye on upcoming earnings and market developments will be crucial as Clorox strives to stabilize and regain investor confidence in a competitive landscape.